Systematic review of first-line chemotherapy for chemo-naïve extensive-stage small-cell lung cancer: network meta-analysis

Samankaltaisia teoksia

• Hazard ratio of progression-free survival is an excellent predictor of overall survival in phase III randomized controlled trials evaluating the first-line chemotherapy for extensive-disease small-cell lung cancer
  Tekijä: Chen, Hao, et al.
  Julkaistu: (2020)
• The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis
  Tekijä: Horita, Nobuyuki, et al.
  Julkaistu: (2017)
• Disease control and objective responsive rates in randomized phase II trials evaluating non-first-line chemotherapy for non-small cell lung cancer: a systematic review of 74 trials
  Tekijä: Matsumoto, Hiromi, et al.
  Julkaistu: (2021)
• Age, Dehydration, Respiratory Failure, Orientation Disturbance, and Blood Pressure Score Predicts In-hospital Mortality in HIV-negative Non-multidrug-resistant Smear-positive Pulmonary Tuberculosis in Japan
  Tekijä: Nagai, Kenjiro, et al.
  Julkaistu: (2016)
• Best regimens for treating chemo‐naïve incurable squamous non‐small cell lung cancer with a programmed death‐ligand 1 tumor proportion score of 1%–49%: A network meta‐analysis
  Tekijä: Nobuhiko Fukuda, et al.
  Julkaistu: (2022-01-01)